Literature DB >> 7356906

Prazosin protein binding in health and disease.

P Rubin, T Blaschke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7356906      PMCID： PMC1429856          DOI： 10.1111/j.1365-2125.1980.tb05830.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  A method to estimate binding constants at variable protein concentrations.

Authors:  J Romer; M H Bickel
Journal:  J Pharm Pharmacol       Date:  1979-01       Impact factor: 3.765

2.  Plasma protein binding of tricyclic anti-depressants in man.

Authors:  O Borgå; D L Azarnoff; G P Forshell; F Sjöqvist
Journal:  Biochem Pharmacol       Date:  1969-09       Impact factor: 5.858

3.  The plasma protein binding of amphetamine, catecholamines and related compounds.

Authors:  G Franksson; E Anggård
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1970

Review 4.  The binding of drugs to plasma proteins from patients with poor renal function.

Authors:  M M Reidenberg
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

5.  Increased plasma binding of quinidine after surgery: a preliminary report.

Authors:  D Fremstad; K Bergerud; J F Haffner; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

Review 6.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

7.  Prazosin determination by high-pressure liquid chromatography using fluorescence detection.

Authors:  Y G Yee; P C Rubin; P Meffin
Journal:  J Chromatogr       Date:  1979-04-21

8.  Pharmacokinetics of prazosin in man.

Authors:  D C Hobbs; T M Twomey; R F Palmer
Journal:  J Clin Pharmacol       Date:  1978 Aug-Sep       Impact factor: 3.126

9.  Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.

Authors:  K M Piafsky; O Borgá; I Odar-Cederlöf; C Johansson; F Sjöqvist
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

10.  Methadone binding to human plasma albumin.

Authors:  G D Olsen
Journal:  Science       Date:  1972-05-05       Impact factor: 47.728
View more
  11 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Neuropsychiatric complications related to use of prazosin in patients with renal failure.

Authors:  D K Chin; A K Ho; C Y Tse
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-22

3.  Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.

Authors:  G Sager; R Jaeger; C Little
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

4.  Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs.

Authors:  T W Guentert; S Oie; L Paalzow; B M Frey; R Brandt; L J Aarons; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

5.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

6.  Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension.

Authors:  P C Rubin; L Butters; R A Low; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

7.  Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man.

Authors:  P Schulz; K M Giacomini; S Luttrell; K Turner-Tamiyasu; T F Blaschke
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus.

Authors:  T S Trovik; R Jaeger; R Jorde; O Ingebretsen; G Sager
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.

Authors:  B Silke; W G Hendry; S H Taylor
Journal:  Br Heart J       Date:  1981-12

Review 10.  Clinical pharmacokinetics of prazosin--1985.

Authors:  J Vincent; P A Meredith; J L Reid; H L Elliott; P C Rubin
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.